Proposed new diagnoses of anxious depression and bodily stress syndrome in ICD-11-PHC: an international focus group study

Lam, Tai-Pong; Goldberg, David; Dowell, Anthony; Fortes, Sandra; Mbatia, Joseph; Minhas, Fareed Aslam; Klinkman, Michael S.

doi:10.1093/fampra/cms037

Cited by 53 publications

(54 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Taxometric analysis using a wide range of symptom items assessed in a sample of 706 adolescents identified a MAD group with 12-13% membership; the MAD taxon predicted the incidence of full mood and anxiety disorders over the subsequent 14 months (Schmidt et al 2007). However, it has being considered as a relevant condition in primary care for ICD-11 (Lam et al 2013). They identified five classes of individuals characterized by increasing severity and decreasing prevalence; non-specific symptoms of negative affect predominated in those with MAD.…”

Section: Introductionmentioning

confidence: 99%

Identification and validation of mixed anxiety–depression

et al. 2015

View full text Add to dashboard Cite

show abstract

Section: Introductionmentioning

confidence: 99%

Identification and validation of mixed anxiety–depression

et al. 2015

View full text Add to dashboard Cite

show abstract

“…These topics were selected because 36 % of general practice attendees report anxiety, depression or substance use, or a combination of these issues [6]. In addition, symptoms of bodily stress (previously referred to as medically unexplained symptoms) are common presentations in primary care settings [20, 21], and are being considered as a new diagnosis (ICD-11-PHC) in the forthcoming International Classification of Diseases [22]. This was reflected in GP feedback that indicated a need for resources on bodily stress.…”

Section: Introductionmentioning

confidence: 99%

Clinical effectiveness of an ultra-brief intervention for common mental health syndromes in primary care: study protocol for a cluster randomized controlled trial

Collings

Mathieson

Dowell

et al. 2015

Trials

View full text Add to dashboard Cite

BackgroundAlthough mild to moderate mental health problems are common and often debilitating, treatment options in primary care settings in New Zealand are often severely limited for patients with these conditions. Previously, we developed an ultra-brief intervention (UBI) to address mild to moderate psychological concerns, designed to be delivered by primary care clinicians. Recent feasibility testing, including an adaptation for Māori individuals (the indigenous people of New Zealand), showed that the brief intervention was feasible and acceptable to both clinicians and their patients. This protocol describes a large pragmatic randomized controlled trial of our UBI in primary care settings across the greater Wellington region, compared with practice as usual.Methods/DesignWe are using a two-arm cluster randomized controlled trial, with primary care practices randomized to exclusively deliver either the UBI or practice as usual to all their recruited participants. The structured, guided self-help UBI is delivered in three brief general practitioner (GP) appointments over a five week period. Participants are invited into the study based on partner primary health organization access criteria (youth, people with low income, or people with Māori or Pacific Island heritage). Improvements in mental health from baseline to post-treatment will be compared between the intervention and control groups using a mixed-models application of analysis of covariance. Data analysis will be on an intention-to-treat basis, to increase the real-world relevance of UBI and to meet the study's objective of releasing UBI to primary care clinicians nationwide.DiscussionThe UBI is a first-line intervention tool for GPs that models the stepped care approach advocated in New Zealand, against a background of limited access to treatments for often-overlooked patient groups. It is proposed to be accessible to clinicians and patients alike, with the potential to be relevant to primary care clinicians across New Zealand.Trial registrationAustralian New Zealand Clinical Trials Registry ACTRN12613000041752.

show abstract

“…Consistent with the literature, the sample was verified to be predominantly feminine. (7) The usage rate of psychiatric drugs observed (25.8%) was higher than the one found in the literature, which ranges from 9 to 13%. (1,2) In regards to the types of psychiatric drugs prescribed, the most prevalent ones were the ones in the class of antidepressants, followed by benzodiazepine drugs.…”

Section: Discussionmentioning

confidence: 51%

“…(5,6) The importance of studies which discuss that subject is justified by the possibility for patients to be guided, not only as to the best therapeutic modality for their cases, but also in regards to the correct use of medications, as the misuse of psychiatric drugs involves the risk of conditions that may be serious. (7) This study aimed at investigating the prevalence in the use of psychiatric drugs in primary health care units, and the possible associations among their use, and socio-demographic and pharmacotherapeutic factors, medical history, and the presence of Common Mental Disorders.…”

Section: Introductionmentioning

confidence: 99%

Prevalência do uso de psicotrópicos e fatores associados na atenção primária à saúde

et al. 2015

View full text Add to dashboard Cite

Objective: Investigating the prevalence in the use of psychotropics and associated factors in primary health care withsocio-demographic and pharmacotherapeutic factors, medical history, and Common Mental Disorders. Methods: A cross-section study which includes 430 primary health care patients. The research instruments were Self-reporting Questionnaires and medical records. A chi-squared test was used in the univariate analysis, and a logistic regression was used in the multivariate analysis. Results: The prevalence in the use of psychotropics was 25.8%. There was an association among the use of psychiatric drugs and common mental disorders, use of non-psychiatric drugs, number of medications prescribed,number of pills a day, clinical pathologies, age, and schooling. In the multivariate analysis, the predictors for the use of psychiatric drugs were: common mental disorders, clinical pathologies, and schooling. Conclusion: The prevalence in the use of psychiatric drugs and the associated factors varied according to the univariate or the multivariate analyses. ResumoObjetivo: Investigar a prevalência de uso de psicotrópicos e fatores associados na atenção primária à saúde com fatores sociodemográficos, farmacoterapêuticos, histórico de saúde e Transtornos Mentais Comuns. Método: Estudo transversal que incluiu 430 pacientes de atenção primária à saúde. O instrumento de pesquisa foi o Self-reporting Questionnaire e prontuários. Para análise, utilizou-se teste Qui-quadrado na análise univariada e regressão logística na multivariada. Resultados: A prevalência de uso de psicotrópicos foi de 25,8%. Houve associação entre uso de psicofármacos e transtornos mentais comuns, uso de medicamentos não psicofármacos, número de medicamentos prescritos, número de comprimidos/dia, patologias clínicas, idade e escolaridade. Na análise multivariada os preditores para uso de psicofármacos foram: transtornos mentais comuns, patologias clínicas e escolaridade. Conclusão: A prevalência de uso de psicofármacos e os fatores associados variaram conforme a análise uni ou multivariada.

show abstract

Proposed new diagnoses of anxious depression and bodily stress syndrome in ICD-11-PHC: an international focus group study

Abstract: Anxious depression is well received by primary care professionals, but BSS requires further modification. International field trials will be held to further test these new diagnoses in draft ICD-11-PHC.

Cited by 53 publications

References 11 publications

Identification and validation of mixed anxiety–depression

Identification and validation of mixed anxiety–depression

Clinical effectiveness of an ultra-brief intervention for common mental health syndromes in primary care: study protocol for a cluster randomized controlled trial

Prevalência do uso de psicotrópicos e fatores associados na atenção primária à saúde

Contact Info

Product

Resources

About